01Mar 2025
Plasma p-tau217 Predicts Cognitive Decline in Unimpaired Individuals

Plasma p-tau217 Predicts Cognitive Decline in Unimpaired Individuals

A study of 215 cognitively unimpaired individuals from the PREVENT-AD cohort found that elevated plasma p-tau217 significantly increased the risk of mild cognitive impairment (HR up to 9.30). Similar findings were observed using CSF and PET biomarkers. These results highlight plasma p-tau217 as a powerful prognostic marker for early detection of cognitive decline and Alzheimer's risk.

  • #neurology

Like

Save

Share